Open AccessPodiatric Adverse Events and Foot Care in Cancer Patients and Survivors
Author(s) -
Mario E. Lacouture,
David J Kopsky,
Raphael Lilker,
Fiona Damstra,
Mecheline H M van der Linden,
Azael Freites-Martínez,
M. Nagel
Publication year - 2018
Publication title -
journal of the american podiatric medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.295
H-Index - 58
eISSN - 8750-7315
pISSN - 1930-8264
DOI - 10.7547/17-010
Subject(s) - medicine , foot (prosody) , adverse effect , quality of life (healthcare) , podiatry , cancer , discontinuation , intensive care medicine , physical therapy , alternative medicine , pathology , philosophy , linguistics , nursing
Cancer is one of the leading causes of mortality and morbidity worldwide. Recent improved therapies have resulted in more patients surviving cancer and living longer. Despite these advances, the majority of patients will develop adverse events from anticancer therapies. Foot alterations, including nail toxicities, hand-foot syndrome, edema, xerosis, hyperkeratosis, and neuropathy, are frequent among cancer patients. These untoward conditions may negatively impact quality of life, and in some cases may result in the interruption or discontinuation of cancer treatments. Appropriate prevention, diagnosis, and management of podiatric adverse events are essential to maintain foot function and health-related quality of life, both of which are critical for the care of cancer patients and survivors. This article shows results related to complaint and impact on quality of life of the Oncology Foot Care program and reviews publications specific to podiatric adverse events related to cancer treatments.